GLP-1

Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass

Effect of a Dietary Supplement on Hormones Involved in Appetite Regulation in Overweight and Obese Adults

A Randomized, Triple-blind, Placebo-controlled Study to Evaluate the Effects of a Supplement on Nutrient Gaps and Gut Health Among Individuals Utilizing GLP-1 RAs

GLP-1RA Effects on Lean Mass and Bone Health in Midlife Women

GLP-1 Medicines and Mental Health Changes

A Trial to Assess Gastrointestinal Responses to Dietary Fibers in Adults Using Weight Loss Medications

Evaluating the Impact of GLP-1 Receptor Agonists With Total Neoadjuvant Therapy in Rectal Cancer

Evaluation of a Nutritional Intervention With Dietary Supplements in People Who Have Recently Lost Weight: Effects on Body Composition, Emotional Health, and Gut Microbiota

The Effect of Pharmacotherapy With GLP-1 and GIP/GLP-1 Analogs on Changes in Qualitative and Quantitative Parameters of the Diet as Well as Metabolic and Behavioral Parameters in Patients With Excess Body Weight

Impact of Probiotic (UltraFlora® Triplebiotic) on Weight Evolution on People After Discontinuation of GLP-1 Treatment.

Behavioral Therapy and GLP-1 Analogue Effects on Binge Eating, Weight, and Coping in Obesity

Glucagon Like Peptide 1 (GLP-1) Booster™ RCT Study

Impact of Multivitamin (PhytoMulti®) and a Probiotic (UltraFlora® Balance Probiotic) on Gut Health of People Taking GLP-1 Medication

Effectiveness of Alternative Therapies in Maintaining Weight Loss Achieved by GLP-1 Medications Post-Cessation

Impact of GLP-1 Receptor Agonists on Patients With IPMN

Effects of Sucralose in Gut Intestinal Microbiota and Postprandial GLP-1

MAINTAIN (Mucosal AblatIoN Therapy After INcretins)

Does GLP-1RA Prevent Deterioration of Metabolic State in Prediabetic and Diabetic Patients Treated With Antipsychotic Medication?

Effects of GLP-1 Agonists on Gastric Volume